Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer disease

Clinicopathologic evidence suggests the pathology of Alzheimer disease (AD) begins many years prior to cognitive symptoms. Biomarkers are required to identify affected individuals during this asymptomatic (“pre-clinical”) stage to permit intervention with potential disease-modifying therapies design...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Fagan, Anne M., Xiong, Chengjie, Jasielec, Mateusz S., Bateman, Randall J., Goate, Alison M., Benzinger, Tammie L.S., Ghetti, Bernardino, Martins, Ralph N., Masters, Colin L., Mayeux, Richard, Ringman, John M., Rossor, Martin N., Salloway, Stephen, Schofield, Peter R., Sperling, Reisa A., Marcus, Daniel, Cairns, Nigel J., Buckles, Virginia D., Ladenson, Jack H., Morris, John C., Holtzman, David M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2014
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4038930/
https://ncbi.nlm.nih.gov/pubmed/24598588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3007901
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items